New Treatment Guidelines to Chronic Lymphocytic Leukemia (CLL): Latest advances & treatments

In this 1-hour webcast, Dr. Versha Banerji, a Canadian leader in CLL treatment and research, have provided the latest information on CLL diagnosis and treatment options. Dr. Banerji spoke about who the disease affects and how it progresses, how decisions are made about when to treat and the factors that influence the choice of treatment, the new CLL treatments guidelines and what the future holds.

Dr. Banerji is a Senior Scientist at the CancerCare Manitoba Research Institute, Associate Professor at the University of Manitoba, and a Clinician-Scientist at CancerCare Manitoba. She Co-leads the CLL clinic and is involved in several clinical trials and population-based treatment studies. As Co-chair of the CLL Research Program, she manages a multi-disciplinary research team in clinical, fundamental and translational research. Her own laboratory is evaluating novel therapeutics and the impact on mitochondrial function and metabolism.

For more information on CLL, visit:
https://www.bloodcancers.ca/I-Have-a-...